Check-Cap Ltd. Stock

$0.89

1.52% yesterday

Nasdaq, May 20, 10:00 pm CET

ISIN

IL0011336851

Symbol

CHEK

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts News Strategies

Check-Cap Ltd. Stock price

$0.89

-11.04 92.51% 5Y

Nasdaq, Closing price Tue, May 20 2025

+0.01 1.53%

ISIN

IL0011336851

Symbol

CHEK

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Medical specialties

Key metrics

Market capitalization	$5.23m
Enterprise Value	$-19.53m
EV/FCF (TTM) EV/FCF	1.19
Revenue (TTM) Revenue	$0.00
EBIT (operating result TTM) EBIT	$-17.86m
Free Cash Flow (TTM) Free Cash Flow	$-16.44m
Cash position	$24.76m
EPS (TTM) EPS	$-3.00
P/E forward	negative
Short interest	0.95%

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Get Started for Free Today

Check-Cap Ltd. Stock Analysis

Unlock Scores for Free

??

2 Analysts have issued a Check-Cap Ltd. forecast:

2x Hold

100%

More details on Analyst Estimates Including Price Targets

2 Analysts have issued a Check-Cap Ltd. forecast:

Hold

100%

Analyst Estimates with Stock Price Targets

Financial data from Check-Cap Ltd.

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Dec '23		+/- %
Revenue	- -	- 100%
- Direct Costs	0.21 0.21	- -
Gross Profit	-0.21 -0.21	- -
- Selling and Administrative Expenses	9.13 9.13	- -
- Research and Development Expense	8.31 8.31	- -
EBITDA	-18 -18	- -
- Depreciation and Amortization	0.21 0.21	- -
EBIT (Operating Income) EBIT	-18 -18	- -
Net Profit	-18 -18	- -

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Check-Cap Ltd. Stock News

Neutral

PRNewsWire

●

7 days ago

Apollo Technology Capital Corporation Poses Questions That MediPharm Shareholders Should Ask on Management's Conference Call with Shareholders

Company Has Suspended Calls Since the Second Quarter of 2024 to Avoid Facing the Music for Board's and Management Team's Destruction of 99% of Stock's Value, Costing Shareholders $1 Billion Conference Call is a Blatant, Self-Serving Reaction by a Management Team Running Scared Following Apollo Capital's Intention to Nominate Six Highly Qualified Directors to MediPharm's Board Shareholders Des...

Neutral

PRNewsWire

●

8 days ago

MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders

TORONTO , May 13, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, has filed its Management Information Circular ("MIC" or the "Circular") and proxy materials (the "Meeting Materials") for its upcoming Annual and Special Meeting of Shareholders, scheduled for June 16, 2025. The Meeting Mate...

Neutral

PRNewsWire

●

13 days ago

Apollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value Destruction

Believes Board Change is Urgently Needed: Under the Current Board and Management, MediPharm Stock Price is Down More Than 99%, Costing Shareholders Nearly $1 Billion MediPharm's Board Cannot be Trusted to Create Shareholder Value or Oversee Management! Company Leadership Lacks Any Credible Strategic Plan and Has Made Numerous Reckless Acquisitions While Rewarding Themselves with Excessive Compe...

Company Profile

Check-Cap Ltd. is a clinical stage medical diagnostics company engaging in the development of ingestible imaging capsule system for colorectal cancer screening. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.

Head office	Israel
CEO	Saar Levi
Founded	2005
Website	www.check-cap.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now